Mental Elf readers have been voting for their favourite topics and top of the list at present are psychological therapies and depression. Us elves like to give people what they want, so here’s a review conducted by researchers in the Netherlands that summarises what we know about the effectiveness of different types of psychotherapy in [read the full story…]
Cannabis (marijuana) is the most widely used illicit drug in the world and reports of driving under the influence of cannabis have risen in recent years. A research team from Dalhousie University in Canada conducted a systematic search and identified observational epidemiology studies of motor vehicle collisions with an appropriate control group. They included studies [read the full story…]
This new systematic review compares how effective first-generation antipsychotics (FGAs) and second-generation antipsychotics (SGAs) are at preventing relapse in patients with schizophrenia. The authors carried out a meta-analysis of 23 randomised controlled trials that lasted for ≥6 months and compared FGAs with SGAs in schizophrenia. The outcomes they studied were: Study defined relapse Relapse at 3, [read the full story…]
In 2004 the US Food and Drug Administration published a “black box” warning that highlighted an increased risk of suicide and suicidal thoughts in young people who were taking antidepressants. This warning was updated in 2007. A new analysis of 41 randomised controlled trials has been published in the Archives of General Psychiatry, which suggests [read the full story…]
We have learnt so much about mental illness in the last few decades and the science behind diagnosing, managing and supporting people with individual conditions has improved dramatically. Despite this improved knowledge, public attitudes to mental health issues remain varied and we still frequently hear horror stories about how people with mental health conditions are [read the full story…]
There’s an interesting review in the British Journal of Psychiatry this week, which compares the effectiveness of psychiatric drugs with those used to treat physical health problems. The headline from the review is that ‘psychiatric drugs are as effective as other drugs’. Professor Stefan Leucht who led the review team claims that: There is a [read the full story…]
There is a growing pool of research that looks into the impact that exercise can have on depression, but this systematic review and meta-analysis claims to be the first summary of trials into the effects of exercise training on depressive symptoms among patients with a chronic illness. The research team from the University of Alabama [read the full story…]
Campaigns in the media that encourage people not to take illicit drugs are now commonplace in the US, but a systematic review of the effectiveness of these interventions has not been conducted until now. A team of researchers from Vancouver in Canada have carried out a systematic review and meta-analysis of 7 randomised controlled trials [read the full story…]
Lithium is a medicine that has been used for over 50 years to treat depression and bipolar disorder. It comes in two forms that are used clinically: lithium carbonate and lithium citrate. A certain level of the drug is needed in the blood stream for it to be effective, but if the level rises too [read the full story…]
Following on from my post yesterday about screening tools for depression in later life, here is a new meta-analysis that explores the efficacy of antidepressants for the treatment of major depressive disorder (MDD) in patients aged ≥ 55 years. The researchers from the University of Modena and Reggio Emilia in Italy just searched PubMed for [read the full story…]
